medigraphic.com
ISSN 2218-6719 (Print)

2021, Number 2

<< Back Next >>

Rev Cub de Tec de la Sal 2021; 12 (2)

Work of optometry and optics technologist in times of covid-19

Pérez FA, Suárez CI, Zazo ERM, Ocaña BIT, Perche AAE, Abreu COL

Language: Spanish
References: 33
Page: 129-135
PDF size: 346.36 Kb.


ABSTRACT

Introduction: the history of modern man and pandemics have marked a before and after in medicine. The last one registered worldwide is currently in charge of the coronavirus. The Optometry and Optics technologist, whose work is close to patients, is at risk of getting and spreading COVID-19, by not using eye protection or by manipulating the eyes. Objective: to identify the work of the technologist in Optometry and Optics in times of COVID-19. Development: the work of the technologist in Optometry and Optics in times of COVID-19 pandemic; as a special situation, it is to put into practice the knowledge acquired for disease prevention and health promotion. In addition to promoting changes in the mode of action, in lifestyles from active research. Taking the temperature, the application of the chlorinated solution in the workplace, consultations, or support the red zone. Conclusions: the work performed by the technologist in Optometry and Optics in times of COVID-19 was identified, in order to contribute to the good of the patient, the family, the community and society.


REFERENCES

  1. Olivares-de JP, Garza M, García G, Azcárate-Coral T, Penniecook JA, Lansingh VC, et al. Recomendaciones para el manejo de pacientes que requieren atención oftalmológica durante la pandemia de SARS-CoV-2. Rev Mex Oftalmol. 2020; 94:2.

  2. Sun P, Lu X, Xu C, Sun X, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol. 2020; 92(1):548-551. [acceso 22/05/2020]. Disponible en: https://doi.org/10.1002/jmv.25722 3.

  3. Palacios M, Santos E, Velázquez MA, León M. COVID-19, una emergencia de salud pública mundial. Rev Clin Esp. [de próxima aparición] 2020. Disponible en: 10.1016/j.rce.2020.03.001 4.

  4. Ahmad A, Rehman MU, Alkharfy KM. An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections. Eur Rev Med Pharmacol Sci. 2020; 24(7):4030-34. Disponible en: 10.26355/eurrev_202004_20873

  5. Yi-Chi W, Ching-Sung C, Yu-Jiun C. The outbreak of COVID-19: an overview. J Chin Med Assoc. [Internet]. 2020.; 83(3):217-220. Disponible en: 10.1097/JCMA.0000000000000270 6.

  6. Peláez O, Más P. Brotes, epidemias, eventos y otros términos epidemiológicos de uso cotidiano. Rev Cub Salud Púb. 2020 [acceso 22/05/2020]; 46(2) Disponible en: http://www.revsaludpublica.sld.cu/index.php/spu/article/view/2358 2.

  7. Seah I, Agrawal R. Can the Coronavirus disease 2019 (COVID-19) affect the eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Oc Immunol Inflam. 2020; 28:391-5.

  8. Lai THT, Tang EWH, Chau SKY, Li KKW. Reply to ocular manifestation, eye protection and COVID-19. Graef Arch Clin Experim Ophthalmol. 2020; 258:1341.

  9. MINSAP. Protocolo Nacional MINSAP vs. COVID-19. La Habana: MINSAP; 2020:1-103.

  10. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [en línea]. 2020 [citado 09/06/2020]; 395:507-13. Disponible en: http://dx.doi.org/10.1016/S0140-6736(20)30211-7

  11. Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Netw Open [en línea]. 2020 Mar [citado 09/06/2020]; 3(4): [aprox. 6 p.]. Disponible en: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2764293

  12. López PJJD, Ponce PA, Cárdenas MA, Giraldo GC, Herrera EA. Coronavirus - COVID 19: Más allá de la enfermedad pulmonar, qué es y qué sabemos del vínculo con el sistema cardiovascular. Rev Colomb Cardiol [en línea]. 2020 Abr [citado 09/06/2020]; 21(2): S0120. Disponible en: https://doi.org/doi:10.1016/j.rccar.2020.04.006

  13. García HR, Rivero SL, Aroche AR, Aldama PI, Hernández NM. COVID-19: en torno al sistema cardiovascular. RAACC [en línea]. 2020 Abr [citado 09/06/2020]; 10(2): e782. Disponible en: http://www.revistaccuba.sld.cu/index.php/revacc/article/view/782/821

  14. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARSCoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol [en línea]. 2020 [citado 09/06/2020]; 7(1):1-4. Disponible en: https://doi.org/doi:10.1002/jmv.25728

  15. Deepak A, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the Cardiologist. Basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies. JACC: BASIC TO TRANSLATIONAL SCIENCE [en línea]. 2020 May [citado 09/06/2020] ; 5(5):518-536. Disponible en: https://doi.org/10.1016/j.jacbts.2020.04.002

  16. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney impairment is associated with in-hospital death of Covid-19 patients. Med Rxiv preprint [en línea]. 2020 [citado 14/07/2020]; [aprox. 21 p.]. Disponible en: https://doi.org/10.1101/2020.02.18.20023242

  17. Martinez RA, Vega VO, Bobadilla NA. Is the kidney a target of SARS-CoV-2? Am J Physiol Renal Physiol [en línea]. 2020 [citado 14/07/2020]; 318: F1454-F1462. Disponible en: https://doi.org/10.1152/ajprenal.00160.2020

  18. Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med [en línea]. 2020 [citado 09/06/2020]; 382(17): e38. Disponible en: https://doi.org/10.1056/nejmc2007575

  19. Rothan HA, Siddappa NB. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoim [en línea]. 2020 May [citado 14/07/2020]; 109: [aprox. 8 p.]. Disponible en: 10.1016/j.jaut.2020.102433

  20. Gauna ME, Bernava JL. Recomendaciones diagnósticas y terapéuticas ante la Respuesta Inmune Trombótica Asociada a Covid-19 (RITAC). CorSalud [en línea]. 2020 [citado 09/06/2020]; 12(1):60-63. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/615/1110

  21. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J [en línea]. 2020 [citado 09/06/2020]. Disponible en: https://doi.org/10.1093/eurheartj/ehaa190

  22. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci [en línea]. 2020 Mar [citado 09/08/2020]; 11(7):995-998. Disponible en: https://doi.org/10.1021/acschemneuro.0c00122

  23. Naicker S, Yang CW, Hwang SJ, Liu BCh, Chen JH, Jha V. The novel coronavirus 2019 epidemic and kidneys. Kidney Int [en línea] 2020 [citado 14/07/2020]. Disponible en: https://doi.org/10.1016/j.kint.2020.03.001

  24. Li RKP, Stewart MW, Powers SLD. Ophthalmologists are more than eye doctors-in memoriam Li Wenliang. Am J Ophthalmol [en línea]. 2020 Mar [citado 09/08/2020]; 36-37. Disponible en: https://dx.doi.org/10.1016/j.ajo.2020.02.014

  25. Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Brit J Ophthalmol. 2020; 104:748-51.

  26. Awadasseid A, Wu Y, Tanaka Y, Zhang W. Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China. Internat J Biol Sci. 2020; 16:1846-60.

  27. Seah I, Agrawal R. Can the Coronavirus disease 2019 (COVID-19) affect the eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Oc Immunol Inflam. 2020; 28:391-5.

  28. Qing H, Li Z, Yang Z, Shi M, Huang Z, Song J, et al. The possibility of COVID-19 transmission from eye to nose. Acta Ophthalmol. 2020; 98:200.

  29. Ping W, Fang D, Chunhua L, Qiang L, Qu X, Liang L, et al. Characteristics of ocular findings of patients With Coronavirus Disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol [en línea]. 2020 Mar [citado 09/08/2020]; 138(5):575-578. Disponible en: http://dx.doi.org/10.1001/jamaophthalmol.2020.1291

  30. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus sin tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol [en línea]. 2020 Mar [citado 09/08/2020]; 1-6. Disponible en: https://dx.doi.org/10.1002/jmv.25725

  31. Sociedad Española de Oftalmología. Recomendaciones para la atención a pacientes oftalmológicos en relación con emergencia COVID-19. SEO [en línea]. 2020 [citado 09/08/2020]; [ aprox 20 pp]. Disponible en: https://www.oftalmoseo.com/documentacion/comunicado_conjunto_oftalmologia_covid19.pdf

  32. Marinho PM, Marcos A, Romano AC, Nascimento H, Belfort R. Retinal findings in patients with COVID-19. Lancet [en línea]. 2020 [citado 09/08/2020]; 395(10237):1610. Disponible en: https://dx.doi.org/10.1016/S0140-6736(20)31014-X

  33. Lu C, Liu X, Jia Z. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet [en línea]. 2020 [citado 09/08/2020]; 6736(20):30313. Disponible en: http://dx.doi.org/10.1016/S0140-6736(20)30313-5




2020     |     www.medigraphic.com